Dance Biopharm Inc

Aerami Therapeutics is a clinical stage biopharmaceutical company based in Brisbane, CA, specializing in the development of innovative inhaled therapies for the treatment of cardiopulmonary conditions. Their proprietary inhalation technology enables the delivery of precision medications for pulmonary arterial hypertension, Type 2 diabetes, and glycemic control in both Type 1 and Type 2 diabetes.

With a commitment to improving the lives of patients, Aerami Therapeutics is dedicated to advancing their lead programs, such as AER-901 inhaled imatinib, which has shown promising results in Phase 1 clinical trials for the treatment of pulmonary arterial hypertension. Through their cutting-edge drug-device combination products, the company aims to open new pathways for cardiopulmonary disease patients, providing them with effective and convenient treatment options.

Generated from the website